GSK Brings Cervarix To India At Higher Price Than Merck's Gardasil; Will Gynecologists and Pediatricians Help GSK Grab Market Share?

MUMBAI - Overcoming a drawn-out registration and approval process, GlaxoSmithKline has finally launched its much awaited vaccine Cerverix in India. Cerverix is used for the prevention of pre-malignant cervical lesions and cervical cancer related to human pappilomavirus (HPV) types 16 and 18

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Archive

More from Scrip